Quantum Pharmaceutical Group Appoints Michael Dobson As Commercial Manager
The Quantum Pharmaceutical Group, a leading manufacturer and provider of medicines and services to the healthcare sector has announced the appointment of Michael Dobson as Commercial Manager for Licensed Product Development.
Reporting to Brian Fisher, Commercial Director at the Quantum Pharmaceutical Group, Dobson will be responsible for capitalising on product development in licensed pharmaceuticals to support the Group’s growth strategy.
“Michael’s extensive knowledge of the pharmaceutical industry and proven track record of successful product launches make him an asset to the Quantum Pharmaceutical Group, where he will help to drive forward the Group’s product development plans,” comments Brian Fisher.
Michael joins the Quantum Pharmaceutical Group from Pharma Nord where he was Head of Sales for Unlicensed Medicines; his success within this role helped to increase the company’s market share within the primary and secondary care sectors.
Posted by: Quantum Webmaster on 17th November 2014